GB2386609C2 - System for the cell-specific and development-specific selection of differentiating embryonic stem cells adult stem cells and embryonic germline cells - Google Patents

System for the cell-specific and development-specific selection of differentiating embryonic stem cells adult stem cells and embryonic germline cells

Info

Publication number
GB2386609C2
GB2386609C2 GB0313260A GB0313260A GB2386609C2 GB 2386609 C2 GB2386609 C2 GB 2386609C2 GB 0313260 A GB0313260 A GB 0313260A GB 0313260 A GB0313260 A GB 0313260A GB 2386609 C2 GB2386609 C2 GB 2386609C2
Authority
GB
United Kingdom
Prior art keywords
specific
stem cells
embryonic
development
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0313260A
Other languages
English (en)
Other versions
GB2386609A (en
GB2386609B (en
GB0313260D0 (en
GB2386609C (en
Inventor
Bernd Fleischmann
Heribert Bohlen
Jurgen Hescheler
Eugen Kolossov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axiogenesis AG
Original Assignee
Axiogenesis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10136702A external-priority patent/DE10136702B4/de
Application filed by Axiogenesis AG filed Critical Axiogenesis AG
Publication of GB0313260D0 publication Critical patent/GB0313260D0/en
Publication of GB2386609A publication Critical patent/GB2386609A/en
Publication of GB2386609B publication Critical patent/GB2386609B/en
Application granted granted Critical
Publication of GB2386609C publication Critical patent/GB2386609C/en
Publication of GB2386609C2 publication Critical patent/GB2386609C2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5026—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5061—Muscle cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Environmental Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB0313260A 2000-12-27 2001-12-27 System for the cell-specific and development-specific selection of differentiating embryonic stem cells adult stem cells and embryonic germline cells Expired - Fee Related GB2386609C2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10065352 2000-12-27
DE10136702A DE10136702B4 (de) 2000-12-27 2001-07-27 System zur zell- und entwicklungsspezifischen Selektion differenzierender embryonaler Stammzellen, adulter Stammzellen und embryonaler Keimbahnzellen
PCT/EP2001/015337 WO2002051987A1 (fr) 2000-12-27 2001-12-27 Systeme de selection specifique aux cellules et au developpement de cellules souches embryonnaires, de cellules souches adultes, et de cellules germinatives embryonnaires de differentiation

Publications (5)

Publication Number Publication Date
GB0313260D0 GB0313260D0 (en) 2003-07-16
GB2386609A GB2386609A (en) 2003-09-24
GB2386609B GB2386609B (en) 2004-12-15
GB2386609C GB2386609C (en) 2013-12-18
GB2386609C2 true GB2386609C2 (en) 2014-01-08

Family

ID=26008109

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0313260A Expired - Fee Related GB2386609C2 (en) 2000-12-27 2001-12-27 System for the cell-specific and development-specific selection of differentiating embryonic stem cells adult stem cells and embryonic germline cells

Country Status (10)

Country Link
US (2) US20040096432A1 (fr)
EP (1) EP1348019B9 (fr)
JP (2) JP4159358B2 (fr)
CN (1) CN100557016C (fr)
AU (1) AU2002217164B9 (fr)
BR (1) BR0116549A (fr)
CA (1) CA2431197C (fr)
GB (1) GB2386609C2 (fr)
IL (1) IL156410A0 (fr)
WO (1) WO2002051987A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19727962A1 (de) * 1997-07-02 1999-01-14 Juergen Hescheler Fluoreszierende Proteine als zelltypspezifische Reporter
US20040234972A1 (en) * 2001-03-20 2004-11-25 Owens Gary K. Method for identifying and purifying smooth muscle progenitor cells
EP1477556A1 (fr) * 2003-05-16 2004-11-17 Heart Biosystems GmbH Méthode de sélection de cellules cardiomyogéniques ou de cardiomyocytes à partir de populations de cellules mixtes
CN1791668A (zh) * 2003-05-20 2006-06-21 独立行政法人理化学研究所 内胚层干细胞的制备
ES2584428T3 (es) * 2003-06-20 2016-09-27 Axiogenesis Ag Modelado de tejidos en un sistema de células madre embrionarias (ES)
ES2365786T3 (es) * 2003-07-08 2011-10-11 Axiogenesis Ag Proteínas secretadas como marcadores para la diferenciación celular.
US8148152B2 (en) * 2003-07-08 2012-04-03 Axiogenesis Ag Method for the preparation of embryoid bodies (EBs) and uses thereof
CA2546942A1 (fr) * 2003-11-24 2005-06-16 The Rockefeller University Procede pour isoler une cellule a cycle lent, pluripotente, se regenerant spontanement
US9945840B2 (en) 2004-04-07 2018-04-17 Axiogenesis Ag Non-invasive, in vitro functional tissue assay systems
CA2565858C (fr) 2004-05-11 2021-06-22 Axiogenesis Ag Dosage pour la decouverte de medicament reposant sur des cellules differenciees in vitro
WO2006014551A2 (fr) * 2004-07-06 2006-02-09 Michigan State University Procedes in vivo pour la realisation de la differenciation specifique tissulaire de cellules souches embryonnaires
US20060110828A1 (en) * 2004-11-24 2006-05-25 Geneprotech, Inc. Compositions and methods for selection of a pure population of cells from a mixed population
US7803619B2 (en) * 2004-11-24 2010-09-28 Geneprotech, Inc. Embryoid body-based screen
CN100420936C (zh) * 2005-08-31 2008-09-24 四川大学 用外源性绿色荧光蛋白进行脂肪成体干细胞标记的方法
EP2007877B1 (fr) * 2006-02-28 2013-04-17 The Trustees of Columbia University in the City of New York Procedes d'agregation compacte de cellules dermiques
WO2010117464A1 (fr) * 2009-04-09 2010-10-14 Sangamo Biosciences, Inc. Intégration ciblée dans des cellules souches
JP6083559B2 (ja) * 2009-07-31 2017-02-22 クロモセル コーポレーション 細胞運命の修飾因子を同定および検証するための方法および組成物
JP5860805B2 (ja) * 2010-03-23 2016-02-16 オリンパス株式会社 幹細胞の分化状態をモニタリングする方法
CN101985629B (zh) * 2010-08-04 2012-10-31 于涛 一种表达载体的制备方法
WO2012098260A1 (fr) 2011-01-21 2012-07-26 Axiogenesis Ag Système non viral pour générer des cellules souches pluripotentes induites (ips)
DE102013114671B4 (de) 2013-12-20 2015-10-29 Universität Rostock Verfahren zur Erzeugung von Sinusknotenzellen ("Herz-Schrittmacherzellen") aus Stammzellen
CN109988807A (zh) * 2017-12-31 2019-07-09 厦门大学 基于hcn4双报告基因获得多能干细胞衍生的高度纯化传导细胞的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464764A (en) * 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US6015671A (en) * 1995-06-07 2000-01-18 Indiana University Foundation Myocardial grafts and cellular compositions
US5602301A (en) * 1993-11-16 1997-02-11 Indiana University Foundation Non-human mammal having a graft and methods of delivering protein to myocardial tissue
DE4441327C1 (de) * 1994-11-22 1995-11-09 Inst Pflanzengenetik & Kultur Embryonale Herzmuskelzellen, ihre Herstellung und ihre Verwendung
DE19615232A1 (de) * 1996-04-18 1997-10-23 Merck Patent Gmbh Neue Carbamoylderivate und deren Verwendung als 5-HT ¶1¶¶A¶-Antagonisten
DE19727962A1 (de) * 1997-07-02 1999-01-14 Juergen Hescheler Fluoreszierende Proteine als zelltypspezifische Reporter
US6080576A (en) * 1998-03-27 2000-06-27 Lexicon Genetics Incorporated Vectors for gene trapping and gene activation
ES2584428T3 (es) * 2003-06-20 2016-09-27 Axiogenesis Ag Modelado de tejidos en un sistema de células madre embrionarias (ES)
US8148152B2 (en) * 2003-07-08 2012-04-03 Axiogenesis Ag Method for the preparation of embryoid bodies (EBs) and uses thereof

Also Published As

Publication number Publication date
JP4891884B2 (ja) 2012-03-07
CA2431197C (fr) 2012-03-13
EP1348019B1 (fr) 2010-07-28
GB2386609A (en) 2003-09-24
GB2386609B (en) 2004-12-15
WO2002051987A1 (fr) 2002-07-04
CN100557016C (zh) 2009-11-04
GB0313260D0 (en) 2003-07-16
EP1348019B9 (fr) 2012-04-18
JP2008118991A (ja) 2008-05-29
JP2004520029A (ja) 2004-07-08
IL156410A0 (en) 2004-01-04
GB2386609C (en) 2013-12-18
CN1483074A (zh) 2004-03-17
AU2002217164B8 (en) 2006-01-05
BR0116549A (pt) 2003-12-23
US20110059456A1 (en) 2011-03-10
CA2431197A1 (fr) 2002-07-04
US20040096432A1 (en) 2004-05-20
JP4159358B2 (ja) 2008-10-01
EP1348019A1 (fr) 2003-10-01
AU2002217164B2 (en) 2005-12-15
AU2002217164B9 (en) 2006-02-09

Similar Documents

Publication Publication Date Title
GB2386609C2 (en) System for the cell-specific and development-specific selection of differentiating embryonic stem cells adult stem cells and embryonic germline cells
IL153095A0 (en) Embryonic stem cells, methods for culturing the same and methods utilizing the same
MX338183B (es) Polipeptidos aislados, polinucleotidos que los codifican, plantas transgenicas quie expresan los mismos y metodos para usarlos.
WO2000053724A3 (fr) Compositions et procedes convenant a la modification de la transcription de genes
WO2002026932A3 (fr) Aptameres d'arn et procede d'identification desdits aptameres
AU2002217164A1 (en) System for the cell-specific and development-specific selection of differentiating embryonic stem cells, adult stem cells and embryonic germline cells
MXPA02004878A (es) Genes relacionados con la bioquimica de la planta.
DK0798378T3 (da) Estrogen-receptor
HK1158529A1 (en) Promoters exhibiting endothelial cell specificity and methods of using same
DK1228227T3 (da) Hankönssterile Brassica-planter samt fremgangsmåder til deres fremstilling
WO1999046370A3 (fr) Expression de genes biosynthetiques de trehalose dans des plantes
AU2001235820A1 (en) Improvements in or relating to fire-fighter training
AU8738401A (en) Novel kallikrein gene
DE60128149D1 (en) Putrescin-n-methyltransferasepromotor
WO2004024940A3 (fr) Modulation d'un gene mediee par arn
WO2002079419A3 (fr) Identification et caracterisation de genes
MX2007004271A (es) Enzimas involucradas en la sintesis de triterpenos.
WO2003101497A8 (fr) Souris inactivees et leur utilisation
WO1997035967A3 (fr) Organismes transgeniques presentant une alteration de l'activite de la telomerase
IT1292743B1 (it) Bruciatore con tubo di venturi, dotato di elementi distributori del flusso di miscela.
DE69832880D1 (de) Frazzled nukleotidsequenzen, expressionsprodukte, zusammensetzungen und verwendungen
WO2002028175A3 (fr) Sousris transgenique pour recombinaison ciblee a mediation par cre-er modifie
WO2001060986A3 (fr) Enzymes hydrolases a activite selective
WO2002052930A3 (fr) Procédé
WO2003040358A1 (fr) Cellules souches embryonnaires derivees de cellules somatiques, et leurs cellules differenciees

Legal Events

Date Code Title Description
S73 Revocation on comptroller's initiative (section 73/patents act 1977)

Free format text: SPECIFICATION AMENDED

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20201227